GLUTATHIONE & RELATED ENZYMES IN CELULAR DRUG RESISTANCE
谷胱甘肽
基本信息
- 批准号:3459576
- 负责人:
- 金额:$ 9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-04-01 至 1995-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Mitomycin C (MMC) is commonly used to treat bladder cancer, the third most
prevalent malignant disease among males in USA. The clinical effectiveness
of MMC is often limited by the emergence of drug resistant tumor cells
through mechanism(s) not completely understood. The overall purpose of
this research proposal is to gain insight into the mechanism(s) of
resistance to MMC with particular emphasis on understanding the role of
glutathione (GSH) and related enzymes in the process. GSH levels will be
compared in sensitive and resistant bladder cancer cells and correlated
with MMC cytotoxicity. In order to further substantiate that the GSH
levels affect MMC response, effect of BSO induced GSH depletion on MMC
cytotoxicity will be studied in vitro in colony forming assay and in vivo
in nude mouse xenografts. In addition, sorting of subsets of cells on the
basis of GSH content will also be attempted to seek correlation between GSH
content and MMC cytotoxicity. The levels of GSH related enzymes,
particularly GSH peroxidases including the novel monomeric form will be
determined in these cells and correlated with MMC cytotoxicity. Since
interrelationship of monomeric peroxidase with other peroxidases is not
known, this enzyme will be purified and characterized. Expression and
characteristics of GSH S-transferase (GST) isoenzymes of normal human
bladder will be investigated to identify tissue specific GSTs. The levels
of GST isoenzymes will be compared in sensitive and resistant cells in
order to see alterations in specific class-toxicity. In order to gain
insight into the mechanism by which GSTs may contribute to MMC resistance,
GST mediated catalytic and non-catalytic detoxification of MMC will be
studied in vitro using purified GST and in situ in sensitive and resistant
cells. Studies will be performed to see if MMC resistance can be reversed
by irreversible inhibitors of GST. MMC induced DNA cross-links will be
quantitated in sensitive and resistant cells by alkaline elution assay.
The extent and levels of enzymes involved in removal of DNA cross-link will
also be compared in these cells. In addition, the contribution of MMC
induced free radical scavengers on free radical generation by ESR
spectroscopy and MMC cytotoxicity in colony forming assay. In long term,
the proposed studies may be helpful in devising strategies to circumvent
cellular resistance to MMC.
丝裂霉素C (MMC)常用于治疗膀胱癌,是第三大药物
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shivendra Singh其他文献
Shivendra Singh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shivendra Singh', 18)}}的其他基金
Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer
萝卜硫素/西兰花芽提取物在前列腺癌中的生物标志物
- 批准号:
10314024 - 财政年份:2019
- 资助金额:
$ 9万 - 项目类别:
The Role of FoxQ1 in Breast Cancer Chemoprevention by Allium Constituents - R01CA219180
FoxQ1 在葱成分预防乳腺癌中的作用 - R01CA219180
- 批准号:
10589846 - 财政年份:2019
- 资助金额:
$ 9万 - 项目类别:
The Role of FoxQ1 in Breast Cancer Chemoprevention by Allium Constituents - R01CA219180
FoxQ1 在葱成分预防乳腺癌中的作用 - R01CA219180
- 批准号:
10374763 - 财政年份:2019
- 资助金额:
$ 9万 - 项目类别:
Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer
萝卜硫素/西兰花芽提取物在前列腺癌中的生物标志物
- 批准号:
10536614 - 财政年份:2019
- 资助金额:
$ 9万 - 项目类别:
Mechanistic Studies on Prostate Cancer Prevention by Gugulipid
古古脂预防前列腺癌的机制研究
- 批准号:
8712195 - 财政年份:2012
- 资助金额:
$ 9万 - 项目类别:
Breast Cancer Prevention by Ayurvedic Medicine Constituents
阿育吠陀医学成分预防乳腺癌
- 批准号:
8590113 - 财政年份:2009
- 资助金额:
$ 9万 - 项目类别:
Breast Cancer Prevention by Ayurvedic Medicine Constituents
阿育吠陀医学成分预防乳腺癌
- 批准号:
8196745 - 财政年份:2009
- 资助金额:
$ 9万 - 项目类别:
Breast Cancer Prevention by Ayurvedic Medicine Constituents
阿育吠陀医学成分预防乳腺癌
- 批准号:
7996575 - 财政年份:2009
- 资助金额:
$ 9万 - 项目类别:
Breast Cancer Prevention by Ayurvedic Medicine Constituents
阿育吠陀医学成分预防乳腺癌
- 批准号:
8996137 - 财政年份:2009
- 资助金额:
$ 9万 - 项目类别:
Breast Cancer Prevention by Ayurvedic Medicine Constituents
阿育吠陀医学成分预防乳腺癌
- 批准号:
7762035 - 财政年份:2009
- 资助金额:
$ 9万 - 项目类别:
相似海外基金
The analysis of proteinuria caused by antineoplastics and the preventative effects with antihypertensive medications using the Japanese medical database
利用日本医学数据库分析抗肿瘤药物引起的蛋白尿及抗高血压药物的预防效果
- 批准号:
21K17258 - 财政年份:2021
- 资助金额:
$ 9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Expediting Drug Development by Profiling Novel Antineoplastics by Mass Spectrometry-based Biomarker Profiling
通过基于质谱的生物标志物分析来分析新型抗肿瘤药物,加速药物开发
- 批准号:
499958-2016 - 财政年份:2016
- 资助金额:
$ 9万 - 项目类别:
Engage Grants Program
Novel Nanoparticle Delivery System for Antineoplastics
新型抗肿瘤纳米颗粒输送系统
- 批准号:
6483914 - 财政年份:2002
- 资助金额:
$ 9万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6124630 - 财政年份:1998
- 资助金额:
$ 9万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6329037 - 财政年份:1998
- 资助金额:
$ 9万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
2747737 - 财政年份:1998
- 资助金额:
$ 9万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459680 - 财政年份:1990
- 资助金额:
$ 9万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459678 - 财政年份:1990
- 资助金额:
$ 9万 - 项目类别: